Clinical Trial Update: Study Evaluating Predictors of Response in Patients With Ankylosing Spondylitis

View source ↗

Summary

Pfizer conducted a study in Ankylosing Spondylitis to identify predictors of treatment response; results were posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis

Snippet

Sponsor: Pfizer | Conditions: Ankylosing Spondylitis | Status: COMPLETED | Results posted: 2012-06-19